Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antisense Pharma investors put in further €8 million as founder CEO steps aside

This article was originally published in Scrip

Executive Summary

Antisense Pharma of Germany has raised €8 million from existing investors MIG Funds and Global Asset Fund. In addition, its co-founder and CEO Dr Karl-Hermann Schlingensiepen is stepping aside as CEO and will now act as a 'strategic consultant' to the company. Dr Schlingensiepen and the investors "developed this solution together", according to the company.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC013594

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel